1. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STPOST 49

    The CORESTA in vitro test battery for combustible tobacco products: update from the 2004 Rationale and Strategy Report

    LEE K.M.(1); JORDAN K.G.(2); WIECZOREK R.(3); MOENNIKES O.(4); CLEMENTS J.(5); CROOKS I.(6); HASHIZUME T.(7); MILLER J.(8); WEBER E.(9); YOSHINO K.(7)
    (1) Altria Client Services, Richmond, VA, U.S.A.; (2) RAI Services Company, Winston-Salem, NC, U.S.A.; (3) Imperial Brands, Reemtsma Cigarettenfabriken GmbH, Hamburg, Germany; (4) PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland; (5) Covance Laboratories Ltd, Harrogate, U.K.; (6) British American Tobacco (Investments) Ltd, R&D, Southampton, U.K.; (7) Japan Tobacco Inc., Yokohama, Kanagawa, Japan; (8) JT International SA, Geneva, Switzerland; (9) Ökolab, Vienna, Austria
    In 2004, the CORESTA In Vitro Toxicity Task Force issued a rationale and strategy report, commonly known as “the CORESTA in vitro test battery guideline”. The goals of this guideline were to: 1) develop the rationale and strategy for conducting in vitro ...
  2. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STPOST 57

    Cross-cultural equivalence of the ABOUT™–Perceived Risk instrument in seven languages

    CHREA C.(1); CANO S.(2); SALZBERGER T.(3); MAINY N.(1); ACQUADRO C.(4); POPIELNICKI A.(5); WEITKUNAT R.(1)
    (1) PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland; (2) Modus Outcomes, Letchworth Garden City, U.K.; (3) University of Economics and Business, Vienna, Austria; (4) Mapi Research Trust, ICON plc, Lyon, France; (5) TransPerfect, Linguistic Validation Group, Boston, MA, U.S.A.
    The risk of smoking has long been well understood by consumers. However, it is important to measure the perceived risks by consumers of novel smoke-free alternatives to cigarettes. The ABOUT™–Perceived Risk instrument was developed to allow the ...
  3. TSRC, Tob. Sci. Res. Conf., 2019, 73, abstr. 012

    Real-time monitoring of volatile organic compounds and aerosol in exhaled breath from inhalation of vapor products and combustible cigarettes

    O'REGAN D.C.(1); OZVALD A.M.(1); HEINE N.(1); GUTMANN R.(2); ROSENKRANZ B.(2)
    (1) JUUL Labs, San Francisco, CA, USA; (2) Ionicon, Innsbruck, Austria
    Exhaled breath (EB) analysis is an attractive methodology for clinical studies, due to its non-invasive nature. Analysis of Volatile Organic Compounds (VOCs) in exhaled breath may facilitate diagnosis of pathological conditions, including potential ...
  4. CORESTA Congress, Kunming, 2018, Agronomy/Phytopathology Groups, APPOST 03

    Using fPAR as a modelling parameter for tobacco yield estimation in regional cropping areas

    BENSE G.(1); BENSE T.(2)
    (1) Teledet SRL, El Pinar, Canelones, Uruguay; (2) C.I.T. Montepaz S.A., Montevideo, Uruguay
    Remote sensing has shown its usefulness in many applications for tobacco crop evaluation: using aerial or satellite collected data, mathematical models could be developed to investigate the status of a crop or to prognosticate its yield. Remote sensing is ...
  5. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 11

    Characterization of flavor transfer during smoking of cigarettes with flavor capsules and aromatized tobacco cigarettes using SPME-GCMS

    RUFENER C.; BANCHERO M.; UMPIERREZ E.; BENSE T.
    C.I.T. Montepaz S.A., Montevideo, Uruguay
    Flavored tobacco has been used in cigarettes for many decades, but nowadays consumption of flavor capsule cigarettes is increasing in South American markets. Flavor capsules give the smoker the option of choosing to smoke the cigarette with or without ...
  6. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 36

    Analysis of the TPD2-related flavor compounds in cigarettes by GC-MS/MS and LC-MS/MS

    ORIKATA N.(1); SATO S.(2); TOBITA T.(1); OGAWA T.(1); NINOMIYA M.(1)
    (1) Japan Tobacco Inc., Product Quality Research Center, Yokohama, Kanagawa, Japan; (2) JTI Ökolab, Vienna, Austria
    The new European Union Tobacco Products Directive (TPD2) came into force in May 2016. The European Commission has established a priority list of 15 additives referred to in Article 6 of TPD2. The purpose of this study was to develop quantitative analysis ...
  7. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 37

    Simultaneous determination of sugar alcohols in cigarettes by LC-MS/MS

    OGAWA T.(1); TOBITA T.(1); ORIKATA N.(1); SATO S.(2); NINOMIYA M.(1)
    (1) Japan Tobacco Inc., Product Quality Research Center, Yokohama, Kanagawa, Japan; (2) JTI Ökolab, Vienna, Austria
    Sugar alcohols are used generally and widely as sweeteners and humectants in the food industry. On the other hand, it is known that some sugar alcohols are present in tobacco leaf and tobacco products such as cigarettes. However, there is no method for ...
  8. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 41

    LC-MS/MS multi-method for the determination of mono- and dicarbonyls in e-liquid and e-cigarette vapor

    POUR G.; WERNETH M.; KUBA M.; OHASHI S.; MAYER-HELM B.; SCHMEISSER E.
    JTI Ökolab, Vienna, Austria
    It is generally accepted that e-liquids and e-cigarette vapor may contain mono- and dicarbonyls. This class of compounds derive either from propylene glycol, glycerol or flavor substances in e-liquids or from thermal degradation during the vaping process. ...
  9. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 58

    Developing fit-for-purpose self-report instruments for assessing consumer responses to tobacco and nicotine products: the ABOUT Toolbox initiative

    CHREA C.(1); SPIES E.(1); AFOLALU E.F.(1); MAINY N.(1); GALLOT S.(1); BINGGELI P.(1); CLERC E.(1); WEITKUNAT R.(1); SALZBERGER T.(2); CANO S.(3); ACQUADRO C.(4); ARNOULD B.(4); LAMBERT J.(4); BRUNEL V.(4); MARCUCCILLI C.(4); ABETZ-WEBB L.(5); ROSE J.(5); FAGERSTRÖM K.(5)
    (1) Philip Morris Products S.A.(part of Philip Morris International group of companies), Neuchâtel, Switzerland; (2) University of Economics and Business, Vienna, Austria; (3) ScaleReport, Ltd, Stotfold, U.K.; (4) Mapi, an ICON plc Company, Lyon, France; (5) Patient-Centered Outcomes Assessments, Ltd, Macclesfield, Cheshire, U.K.; (6) Rose Research Center, Raleigh, NC, U.S.A.; (7) K. Fagerström Consulting AB, Vaxholm, Sweden
    Assessing the full potential of reduced risk products (RRP), for individual users and the population as a whole, requires the assessment of consumer perception and behavior associated with tobacco and nicotine products (TNP) with different exposure and ...